The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic

BACKGROUND: Patients with inflammatory bowel disease (IBD) often require the use of immunosuppressant medications that increase infection risk, leading to concerns over the safe use of IBD medications during the Coronavirus 19 (COVID-19) pandemic. OBJECTIVES: To summarize available evidence on the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamath, Chethana, Brenner, Erica J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040409/
https://www.ncbi.nlm.nih.gov/pubmed/35496814
http://dx.doi.org/10.1016/j.crphar.2022.100101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040409/
https://www.ncbi.nlm.nih.gov/pubmed/35496814
http://dx.doi.org/10.1016/j.crphar.2022.100101

Ejemplares similares